팽윤성 코어를 포함하는 TYK2 억제제를 위한 투여 형태

팽윤성 코어 투여 형태는 무정형 6-(시클로프로판아미도)-4-((2-메톡시-3-(1-메틸-1H-1,2,4-트리아졸-3-일)페닐)아미노)-N-(메틸-d3)피리다진-3-카르복스아미드의 분산물을 포함한다. A swellable core dosage form comprises a dispersion of amorphous 6-(cyclopropancamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KOEHLER KING DORY, SATHER CRAIG ALLEN, BADAWY SHERIF IBRAHIM FARAG, KYBURZ KYLE, KESTUR UMESH
Format:	Patent
Sprache:	kor
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	팽윤성 코어 투여 형태는 무정형 6-(시클로프로판아미도)-4-((2-메톡시-3-(1-메틸-1H-1,2,4-트리아졸-3-일)페닐)아미노)-N-(메틸-d3)피리다진-3-카르복스아미드의 분산물을 포함한다. A swellable core dosage form comprises a dispersion of amorphous 6-(cyclopropancamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide.